Cited by 508Mathematical Biology Tumor GrowthAngiogenesis and VEGF in CancerCancer Cells and Metastasis

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Combining two strategies to improve perfusion and drug delivery in solid tumors

Open access

Stylianopoulos, Triantafyllos, Jain, Rakesh K.·2013·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1318415110PMC PMC3832007

Open this paper in CoChat — free account

Abstract

Blood perfusion in tumors can be significantly lower than that in the surrounding normal tissue owing to the leakiness and/or compression of tumor blood vessels. Impaired perfusion reduces oxygen supply and results in a hypoxic microenvironment. Hypoxia promotes tumor progression and immunosuppression, and enhances the invasive and metastatic potential of cancer cells. Furthermore, poor perfusion lowers the delivery of systemically administered drugs. Therapeutic strategies to improve perfusion include reduction in vascular permeability by vascular normalization and vascular decompression by alleviating physical forces (solid stress) inside tumors. Both strategies have shown promise, but guidelines on how to use these strategies optimally are lacking. To this end, we developed a mathematical model to guide the optimal use of these strategies. The model accounts for vascular, transvascular, and interstitial fluid and drug transport as well as the diameter and permeability of tumor vessels. Model simulations reveal an optimal perfusion region when vessels are uncompressed, but not very leaky. Within this region, intratumoral distribution of drugs is optimized, particularly for drugs 10 nm in diameter or smaller and of low binding affinity. Therefore, treatments should modify vessel diameter and/or permeability such that perfusion is optimal. Vascular normalization is more effective for hyperpermeable but largely uncompressed vessels (e.g., glioblastomas), whereas solid stress alleviation is more beneficial for compressed but less-permeable vessels (e.g., pancreatic ductal adenocarcinomas). In the case of tumors with hyperpermeable and compressed vessels (e.g., subset of mammary carcinomas), the two strategies need to be combined for improved treatment outcomes.

Integrity signals

Registry

Crossref · 10.1073/pnas.1318415110

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Gradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,739
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,364
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101
Self-citation
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031
Self-citation
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857
Self-citation
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Mancuso, M. R., Davis, R. B., Norberg, S. M., O’Brien, S., Sennino, B., Nakahara, T., Yao, V., Inai, T., Brooks, P. C., Freimark, B. D., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24612 · Cited by 814
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
Self-citation
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Thurber, G. M., Schmidt, M. M., & Wittrup, K. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.012 · Cited by 642
Coagulation and cancer: biological and clinical aspects
Falanga, A., Marchetti, M., & Vignoli, A. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12075 · Cited by 566
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Stockmann, C., Doedens, A. L., Weidemann, A., Zhang, N., Takeda, N., Greenberg, J. I., Cheresh, D. A., & Johnson, R. S. (2008) · Nature · doi:10.1038/nature07445 · Cited by 489
FLOW THROUGH INTERSTITIUM AND OTHER FIBROUS MATRICES
Levick, J. R. (1987) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1987.sp003085 · Cited by 485
Diffusion and convection in normal and neoplastic tissues.
Swabb, E. A., Wei, J., & Gullino, P. M. (1974) · PubMed · Cited by 398
Transport of fluid and macromolecules in tumors
Baxter, L. T., & Jain, R. K. (1991) · Microvascular Research · doi:10.1016/0026-2862(91)90003-t · Cited by 391
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Batchelor, T. T., Gerstner, E. R., Emblem, K. E., Duda, D. G., Kalpathy–Cramer, J., Snuderl, M., Ancukiewicz, M., Polaskova, P., Pinho, M. C., Jennings, D. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318022110 · Cited by 353
Untitled work
(1999) · PubMed · Cited by 348
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: Implications for scheduling of anti-angiogenic drugs
Van der Veldt, A. A. M., Lubberink, M., Bahce, I., Walraven, M., de Boer, M. P., Greuter, H. N. J. M., Hendrikse, N. H., Eriksson, J., Windhorst, A. D., Postmus, P. E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.023 · Cited by 337
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., Ancukiewicz, M., Boucher, Y., Jain, R. K., & Xu, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117610109 · Cited by 332
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
Sorensen, A. G., Emblem, K. E., Polaskova, P., Jennings, D. L., Kim, H., Ancukiewicz, M., Wang, M., Wen, P. Y., Ivy, P. S., Batchelor, T. T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2464 · Cited by 298
Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization
Dings, R. P. M., Loren, M. L., Heun‐Johnson, H., McNiel, E. A., Griffioen, A. W., Mayo, K. H., & Griffin, R. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2441 · Cited by 287
Role of Tumor Vascular Architecture in Nutrient and Drug Delivery: An Invasion Percolation-Based Network Model
Baish, J. W., Gazit, Y., Berk, D. A., Nozue, M., Baxter, L. T., & Jain, R. K. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0031 · Cited by 273
The shunt problem: control of functional shunting in normal and tumour vasculature
Pries, A. R., Höpfner, M., le Noble, F. A. C., Dewhirst, M. W., & Secomb, T. W. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2895 · Cited by 264
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
Emblem, K. E., Mouridsen, K., Bjørnerud, A., Farrar, C. T., Jennings, D. L., Borra, R., Wen, P. Y., Ivy, P. S., Batchelor, T. T., Rosen, B. R., et al. (2013) · Nature Medicine · doi:10.1038/nm.3289 · Cited by 251
A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB
Kindler, H. L., Niedzwiecki, D., Hollis, D. R., Oraefo, E., Schrag, D., Hurwitz, H. I., McLeod, H. L., Mulcahy, M. F., Schilsky, R. L., & Goldberg, R. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4508 · Cited by 235
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
Kamoun, W. S., Chae, S., Lacorre, D. A., Tyrrell, J. A., Mitre, M., Gillissen, M. A., Fukumura, D., Jain, R. K., & Munn, L. L. (2010) · Nature Methods · doi:10.1038/nmeth.1475 · Cited by 214
Perivascular nitric oxide gradients normalize tumor vasculature
Kashiwagi, S., Tsukada, K., Xu, L., Miyazaki, J., Kozin, S. V., Tyrrell, J. A., Sessa, W. C., Gerweck, L. E., Jain, R. K., & Fukumura, D. (2008) · Nature Medicine · doi:10.1038/nm1730 · Cited by 184
Effect of Transvascular Fluid Exchange on Pressure–Flow Relationship in Tumors: A Proposed Mechanism for Tumor Blood Flow Heterogeneity
Netti, P. A., Roberge, S., Boucher, Y., Baxter, L. T., & Jain, R. K. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0041 · Cited by 183
Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
Nakai, Y., Isayama, H., Ijichi, H., Sasaki, T., Sasahira, N., Hirano, K., Kogure, H., Kawakubo, K., Yagioka, H., Yashima, Y., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605955 · Cited by 172
Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions.
Fukumura, D., Yuan, F., Mitsuhiro, E. N. D. O., & Jain, R. K. (1997) · Europe PMC (PubMed Central) · Cited by 164
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
Wilop, S., von Hobe, S., Crysandt, M. M., Esser, A., Osieka, R., & Jost, E. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0587-3 · Cited by 163
Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
Qayum, N., Muschel, R. J., Im, J. H., Balathasan, L., Koch, C. J., Patel, S. K., McKenna, W. G., & Bernhard, E. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0657 · Cited by 146
Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation
McGee, M. C., Hamner, J. B., Williams, R. F., Rosati, S. F., Sims, T. L., Ng, C. Y., Gaber, M. W., Calabrese, C. R., Wu, J., Nathwani, A. C., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.010 · Cited by 144
Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model
Stylianopoulos, T., Soteriou, K., Fukumura, D., & Jain, R. K. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0630-4 · Cited by 139
Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia
Matsumoto, S., Batra, S., Saito, K., Yasui, H., Choudhuri, R., Gadisetti, C., Subramanian, S., Devasahayam, N., Munasinghe, J., Mitchell, J. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2025 · Cited by 129
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
Keizman, D., Huang, P., Eisenberger, M. A., Пили, Р., Kim, J., Antonarakis, E. S., Hammers, H. J., & Carducci, M. A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.019 · Cited by 126
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity
de Oliveira, R. L., Deschoemaeker, S., Henze, A., Debackere, K., Finisguerra, V., Takeda, Y., Roncal, C., Dettori, D., Tack, E., Jönsson, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.028 · Cited by 125
Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake
Arjaans, M., Munnink, T. H. O., Oosting, S. F., van Scheltinga, A. G. T. T., Gietema, J. A., Garbacik, E. T., Timmer‐Bosscha, H., Hooge, M. N. L., Schroder, C. P., & de Vries, E. G. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3518 · Cited by 124
Effects of Vascular-Endothelial Protein Tyrosine Phosphatase Inhibition on Breast Cancer Vasculature and Metastatic Progression
Goel, S., Gupta, N., Walcott, B. P., Snuderl, M., Kesler, C. T., Kirkpatrick, N. D., Heishi, T., Huang, Y., Martin, J. D., Ager, E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt164 · Cited by 117
Small GTPase R-Ras Regulates Integrity and Functionality of Tumor Blood Vessels
Sawada, J., Urakami, T., Li, F., Urakami, A., Zhu, W., Fukuda, M., Li, D. Y., Ruoslahti, E. I., & Komatsu, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.013 · Cited by 110
Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn
Chen, Y., & Balthasar, J. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9395-9 · Cited by 105
Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
Pastuskovas, C. V., Mundo, E. E., Williams, S. P., Nayak, T. K., Ho, J., Ulufatu, S., Clark, S., Ross, S., Cheng, E., Parsons-Reponte, K., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0742-t · Cited by 103
Mathematical Modeling of Herpes Simplex Virus Distribution in Solid Tumors: Implications for Cancer Gene Therapy
Mok, W., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2082 · Cited by 84
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
Hidalgo, M. M., & Hoff, D. D. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1327 · Cited by 81
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
Moyal, E. C., Evans, S. M., Koch, C. J., Muschel, R. J., McKenna, W. G., Wu, J., & Bernhard, E. J. (2001) · PubMed · Cited by 71
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
Delmas, C., End, D. W., Rochaix, P., Favre, G., Toulas, C., & Moyal, E. C. (2003) · PubMed · Cited by 70
Normalization of the tumor vasculature through oncogenic inhibition: An emerging paradigm in tumor biology
Goel, S., Fukumura, D., & Jain, R. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203794109 · Cited by 39
Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates.
Hoff, D. D. V., Ervin, T. J., Arena, F. P., Chiorean, E. G., Infante, J. R., Moore, M. J., Seay, T. E., Tjulandin, S., Ma, W. W., Saleh, M. N., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.4005 · Cited by 38
Decrease in Tumor Apparent Permeability‐Surface Area Product to a MRI Macromolecular Contrast Medium Following Angiogenesis Inhibition with Correlations to Cytotoxic Drug Accumulation
Daldrup-Link, H. E., Okuhata, Y., WOLFE, A., SRIVASTAV, S., ØIE, S., FERRARA, N., Cohen, R. L., Shames, D. M., & Brasch, R. C. (2004) · Microcirculation · doi:10.1080/10739680490457665 · Cited by 36
Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment
Eichhorn, M., Strieth, S., Luedemann, S., Kleespies, A., Nöth, U., Passon, A., Brix, G., Jauch, K. ‐., Bruns, C. J., & Dellian, M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.5997 · Cited by 28
Targeting angiogenesis in pancreatic cancer
Philip, P. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60770-9 · Cited by 14

Sorted by citations

Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
WICKI, A. N., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,962
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z., Chen, H., Zheng, L., Sun, L., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,486

See all 508

Authors: Stylianopoulos, T., & Jain, R. K.
Affiliations: University of Cyprus (CY)
Harvard University (US)
ORCID: Stylianopoulos, Triantafyllos
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2013-10-28
Volume: 110
Issue: 46
Pages: 18632-18637
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1318415110
PMC: PMC3832007
OpenAlex: W1964128680
Cited by: 508
References: 67
Citations by year: 2026: 49 · 2025: 46 · 2024: 45 · 2023: 47 · 2022: 29 · 2021: 35 · 2020: 53 · 2019: 29 · 2018: 39 · 2017: 35 · 2016: 34 · 2015: 47 · 2014: 19 · 2013: 1
FWCI: 34.83
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: other-oa
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion, other-oa)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA115767, T32CA073479, R01CA085140, R01CA096915, P01CA080124, R01CA126642, R01CA098706)
Topics: Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: tumor perfusion, drug delivery, solid tumors, vascular normalization, solid stress, tumor hypoxia, vascular permeability, interstitial fluid flow, mathematical model, drug distribution, glioblastoma, pancreatic ductal adenocarcinoma, breast cancer
MeSH terms: Biomechanical Phenomena, Capillary Permeability, Computer Simulation, Humans, Models, Biological, Neoplasms, Regional Blood Flow, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Combining two strategies to improve perfusion and drug delivery in solid tumors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks